Research is not commercial evidence

Research can tell you a great deal about a market.

It can help you understand size, growth, regulation, competitors, channels, price levels and buyer segments.

What it cannot tell you on its own is how the market will respond to your company.

That requires contact.

A market-entry decision becomes stronger when assumptions move through four states:

The gap between ASSUMED and OBSERVED is where many market-entry plans become fragile.

A buyer segment can look attractive on paper and ignore the offer.

A distributor can sound enthusiastic and still fail to create qualified movement.

A competitor's presence can prove demand exists without proving your proposition is relevant.

A market report can identify opportunity without telling you whether the right decision-makers will engage.

This does not make research less valuable.

It makes its role clearer.

Research builds the hypothesis.

Commercial interaction tests it.

Useful evidence may include:

• Response from priority accounts
• Access to relevant decision-makers
• Recurring buyer questions
• Repeated objections
• Language buyers use to describe the problem
• Movement from conversation to next action
• Qualified opportunity signals
• Recurring blockers
• Evidence that a segment, message or proposition should be prioritised — or deprioritised

Not every reply is traction.

Not every meeting is validation.

Not every expression of interest deserves investment.

The value comes from patterns, progression and context.

A strong market-validation process should therefore ask:

1. What do we know?
2. What are we assuming?
3. What has the market actually shown us?
4. What should change because of it?

That is the transition from research to commercial evidence.

And it is often the point where a market thesis becomes more useful — because it has finally been allowed to be wrong.